Sign In

Eugene Sun

Senior Vice President, Research and Development at TB Alliance

Eugene Sun, MD, is the Senior Vice President for Research and Development at TB Alliance, a position he has held since June 2019.13 In this role, he oversees TB Alliance's drug development portfolio, from discovery stage projects to regimen selection, clinical trials, and global regulatory submissions.13

Dr. Sun has an extensive background in pharmaceutical research and development, particularly in infectious diseases:

  1. Education and Training:

    • Undergraduate degree from Harvard University
    • Medical degree from NYU School of Medicine
    • Completed internship, residency in internal medicine, and fellowship in infectious diseases at the University of California, San Francisco14
  2. Professional Experience:

    • Senior Advisor to the Biomedical Advanced Research and Development Authority (BARDA) in the US Department of Health and Human Services (HHS)1
    • CEO of Melinta Therapeutics, an antibiotic-focused company, from 2015 to 20172
    • 17-year career at Abbott Laboratories, reaching the position of Corporate Vice President, Global Pharmaceutical Clinical Development12
    • Served on the U.S. Food and Drug Administration (FDA) Antiviral Drugs Advisory Committee from 2001 to 200724

Dr. Sun's expertise in global drug development and product registration is considered invaluable to advancing TB Alliance's pipeline and benefiting millions in need of new TB therapies.3 His LinkedIn username is eugene-sun-9709aba.5

Related Questions

What are Eugene Sun's key achievements at TB Alliance?
How has Eugene Sun's experience at BARDA influenced his work at TB Alliance?
What challenges does Eugene Sun face in developing new TB treatments?
How does Eugene Sun's background in infectious diseases benefit TB Alliance's mission?
What are some of the notable projects Eugene Sun has led at Abbott Laboratories?
Eugene Sun
Eugene Sun, photo 1
Eugene Sun, photo 2
Add to my network

Location

New York, New York, United States